Literature DB >> 8190112

125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

M E Olah1, C Gallo-Rodriguez, K A Jacobson, G L Stiles.   

Abstract

The rat A3 adenosine receptor (AR) is a recently characterized AR subtype cloned from testis and brain cDNA libraries. N6-2-(4-Amino-3-[125I]iodophenyl)ethyladenosine, a high affinity A1AR agonist, has served as the only radioligand available for study of the A3AR. The relatively low affinity of N6-2-(4-amino-3-[125I] iodophenyl)ethyladenosine for the A3AR and its greater A1AR selectivity necessitate the development of more appropriate radioligands for A3AR analysis. This report characterizes 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I-AB-MECA), a high affinity radioligand for the A3AR, in two cell lines that express this AR subtype. Membranes from Chinese hamster ovary (CHO) cells expressing the rat A3AR and from the rat mast cell line RBL-2H3 bound 125I-AB-MECA with Kd values of 1.48 +/- 0.33 nM and 3.61 +/- 0.30 nM, respectively. As determined by 125I-AB-MECA binding, levels of A3AR expression in the A3AR-CHO cell line and RBL-2H3 cells were 3.06 +/- 0.21 pmol/mg and 1.02 +/- 0.13 pmol/mg, respectively. Binding of 125I-AB-MECA was characterized in competition assays. In the A3AR-CHO cell line a potency order of cyclohexyl-5'-N-ethylcarboxamidoadenosine (cyclohexyl-NECA) = benzyl-NECA > (-)-N6-[(R)-phenylisopropyl]adenosine = NECA was observed, and in RBL-2H3 cells (-)-N6-[(R)-phenylisopropyl]adenosine and NECA were equipotent. Xanthine amine congener (XAC) and 8-cyclopentyl-1,3-dipropylxanthine did not significantly inhibit 125I-AB-MECA binding. The parent compound, AB-MECA, dose-dependently inhibited forskolin-stimulated adenylyl cyclase activity in A3AR-CHO cell membranes. 125I-AB-MECA bound to the rat A1AR and canine A2aAR expressed in COS-7 cells with Kd values of 3.42 +/- 0.43 nM and 25.1 +/- 12.6 nM, respectively. This binding was significantly reduced in the presence of 1 microM XAC. In RBL-2H3 cells, XAC had no effect on 125I-AB-MECA affinity and reduced the level of radioligand binding by approximately 5%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190112      PMCID: PMC5553074     

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

Review 1.  Adenosine receptors.

Authors:  M E Olah; G L Stiles
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Authors:  M E Olah; H Ren; J Ostrowski; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

3.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 4.  Cloned receptors and cardiovascular responses to adenosine.

Authors:  A L Tucker; J Linden
Journal:  Cardiovasc Res       Date:  1993-01       Impact factor: 10.787

5.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.

Authors:  R A Olsson; S Kusachi; R D Thompson; D Ukena; W Padgett; J W Daly
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

8.  Purification of A1 adenosine receptor from rat brain membranes.

Authors:  H Nakata
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

9.  Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Authors:  J Linden; H E Taylor; A S Robeva; A L Tucker; J H Stehle; S A Rivkees; J S Fink; S M Reppert
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

10.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  77 in total

1.  Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.

Authors:  B C Suh; T D Kim; J U Lee; J K Seong; K T Kim
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modifications.

Authors:  K Lee; G Ravi; X D Ji; V E Marquez; K A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2001-05-21       Impact factor: 2.823

3.  A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

Authors:  M L Trincavelli; D Tuscano; M Marroni; A Falleni; V Gremigni; S Ceruti; M P Abbracchio; K A Jacobson; F Cattabeni; C Martini
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

4.  Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.

Authors:  Xiyan Hou; Mahesh S Majik; Kyunglim Kim; Yuna Pyee; Yoonji Lee; Varughese Alexander; Hwa-Jin Chung; Hyuk Woo Lee; Girish Chandra; Jin Hee Lee; Seul-Gi Park; Won Jun Choi; Hea Ok Kim; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson; Sun Choi; Sang Kook Lee; Lak Shin Jeong
Journal:  J Med Chem       Date:  2011-12-28       Impact factor: 7.446

5.  Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

Authors:  Z G Gao; J E Van Muijlwijk-Koezen; A Chen; C E Müller; A P Ijzerman; K A Jacobson
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

6.  Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold.

Authors:  T Santhosh Kumar; Shilpi Mishra; Francesca Deflorian; Lena S Yoo; Khai Phan; Miklos Kecskés; Angela Szabo; Bidhan Shinkre; Zhan-Guo Gao; William Trenkle; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

7.  Discovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.

Authors:  Xiyan Hou; Hea Ok Kim; Varughese Alexander; Kyunglim Kim; Sun Choi; Seul-Gi Park; Jin Hee Lee; Lena S Yoo; Zhan-Guo Gao; Kenneth A Jacobson; Lak Shin Jeong
Journal:  ACS Med Chem Lett       Date:  2010-09-01       Impact factor: 4.345

8.  Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

Authors:  H O Kim; X D Ji; N Melman; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

9.  Species comparison of adenosine receptor subtypes in brain and testis.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Laura Fabbrini; Lara Schmid; Maura Castagna; Laura Giusti; Giovanni Mascia; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-07       Impact factor: 3.996

10.  Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

Authors:  A H Li; S Moro; N Melman; X D Ji; K A Jacobson
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.